Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03272334 |
|---|---|
| Brief Title: | Her2-BATS and Pembrolizumab in Metastatic Breast Cancer (Breast-47) |
| First Submitted : | August 28, 2017 |
| First Submitted that Met QC Criteria : | August 31, 2017 |
| First Posted : | September 5, 2017 |
| Last Update Submitted that Met QC Criteria : | May 7, 2020 |
| Last Update Posted : | May 8, 2020 |